Trials / Unknown
UnknownNCT05744297
NLRP3 Inflammasome Activation Among Patients During Acute Gout Flares
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Centre Hospitalier Saint Joseph Saint Luc de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Gout is a chronic joint disease associated with deposition of monosodium urate crystals, as a consequence of hyperuricemia. Gout is an intermittent flaring condition and acute gout flares are driven by NLRP3 inflammasome and IL1-beta production. However pathogenesis of acute gout flares remains poorly known in vivo in human. The aim of this study is to evaluate NLRP3 inflammasome activation in vivo in patients cells during acute gout flares.
Detailed description
Blood and synovial fluid will be obtained from remainder of patients' samples during an acute gout flares. White blood cells will be isolated and NLRP3 inflammasome activation will be assessed. Then, NLRP3 inflammasome inhibitors will be tested on cells with NLRP3 inflammasome activity.
Conditions
Timeline
- Start date
- 2023-04-28
- Primary completion
- 2023-06-01
- Completion
- 2023-10-01
- First posted
- 2023-02-27
- Last updated
- 2023-05-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05744297. Inclusion in this directory is not an endorsement.